Chemomab Therapeutics (CMMB) PT Raised to $25 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jeff Jones raised the price target on Chemomab Therapeutics (NASDAQ: CMMB) to $25.00 (from $10.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
